295 related articles for article (PubMed ID: 36770942)
1. Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.
Manetti D; Dei S; Arias HR; Braconi L; Gabellini A; Teodori E; Romanelli MN
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770942
[TBL] [Abstract][Full Text] [Related]
2. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
[TBL] [Abstract][Full Text] [Related]
4. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
Sanders VR; Millar NS
Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
[TBL] [Abstract][Full Text] [Related]
5. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
Collins T; Young GT; Millar NS
Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
[TBL] [Abstract][Full Text] [Related]
6. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
8. Insights Into the Differential Desensitization of
Papke RL; Stokes C
Mol Pharmacol; 2023 Feb; 103(2):63-76. PubMed ID: 36414373
[TBL] [Abstract][Full Text] [Related]
9. Allosteric Agonism of
Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
[TBL] [Abstract][Full Text] [Related]
10. A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties.
Gill JK; Dhankher P; Sheppard TD; Sher E; Millar NS
Mol Pharmacol; 2012 May; 81(5):710-8. PubMed ID: 22328718
[TBL] [Abstract][Full Text] [Related]
11. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
12. Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.
Horenstein NA; Papke RL; Kulkarni AR; Chaturbhuj GU; Stokes C; Manther K; Thakur GA
J Biol Chem; 2016 Mar; 291(10):5049-67. PubMed ID: 26742843
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.
Pandya A; Yakel JL
Biochem Pharmacol; 2011 Oct; 82(8):952-8. PubMed ID: 21596025
[TBL] [Abstract][Full Text] [Related]
14. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
15. Silent agonists for α7 nicotinic acetylcholine receptors.
Papke RL; Quadri M; Gulsevin A
Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
[TBL] [Abstract][Full Text] [Related]
16. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Faghih R; Gfesser GA; Gopalakrishnan M
Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220
[TBL] [Abstract][Full Text] [Related]
17. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulation of nicotinic acetylcholine receptors.
Chatzidaki A; Millar NS
Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
[TBL] [Abstract][Full Text] [Related]
19. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
[TBL] [Abstract][Full Text] [Related]
20. Differential Activation and Desensitization States Promoted by Noncanonical
Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL
J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
